Karen L. McFarlane Holman, Ph.D.
Affiliations: | 2001- | Chemistry | Willamette University, Salem, Oregon |
Area:
ruthenium anti-cancer drugs, photochemistry, organometallics, XANES, OEC in PSIIGoogle:
"Karen McFarlane Holman"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Peter C. Ford | grad student | 1990-1996 | UC Santa Barbara | |
| (Ford Group Rocks!) | ||||
| Melvin P. Klein | post-doc | UC Berkeley/LBNL | ||
| (XANES & EXAFS on OEC in PSII) | ||||
Children
Sign in to add trainee| Jerry L. LaRue | research assistant | Willamette University, Salem, Oregon | |
| Christopher B. Whitehead | research assistant | Willamette University, Salem, Oregon |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hinton SR, Corpuz ELS, McFarlane Holman KL, et al. (2022) A split β-lactamase sensor for the detection of DNA modification by cisplatin and ruthenium-based chemotherapeutic drugs. Journal of Inorganic Biochemistry. 236: 111986 |
| Dwyer BG, Johnson E, Cazares E, et al. (2018) Ruthenium anticancer agent KP1019 binds more tightly than NAMI-A to tRNA. Journal of Inorganic Biochemistry. 182: 177-183 |